enGene Holdings Inc.
NASDAQ Capital MarketTotal Valuation
enGene Holdings Inc. carries a market capitalization of 98.81M, placing it among publicly traded companies globally. Its enterprise value stands at 230.68M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 98.81M |
| Enterprise Value | 230.68M |
Share Statistics
enGene Holdings Inc. currently has 66.99M shares outstanding.
| Shares Outstanding | 66.99M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 2.28 |
| P/TBV Ratio | 1.79 |
| P/FCF Ratio | -4.20 |
| P/OCF Ratio | -4.14 |
Financial Position
enGene Holdings Inc. maintains a current ratio of 12.57, meaning it holds 12.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.07, indicating elevated leverage, while an interest coverage ratio of -44.19 demonstrates limited ability to service its debt obligations.
| Current Ratio | 12.57 |
| Quick Ratio | 12.07 |
| Debt / Equity | 13.07 |
| Debt / EBITDA | -0.25 |
| Interest Coverage | -44.19 |
Financial Efficiency
| Return on Equity (ROE) | -62.65 |
| Return on Assets (ROA) | -44.19 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | -258,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
enGene Holdings Inc.'s stock has declined approximately -50% over the past 52 weeks. The 50-day moving average sits at 1.74, while the 200-day moving average is 6.64.
| Beta (5Y) | N/A |
| 52-Week Price Change | -50% |
| 50-Day Moving Average | 1.74 |
| 200-Day Moving Average | 6.64 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -131.91M, while operating income came in at -132.58M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -132.58M |
| Pretax Income | -127.11M |
| Net Income | -126.85M |
| EBITDA | -131.91M |
| EBIT | -132.58M |
| Earnings Per Share (EPS) | -2.02 |
Balance Sheet
enGene Holdings Inc. holds 258.47M in cash and equivalents against 33.35M in total debt, resulting in a net debt position of -4.72M. Total book value stands at 199.98M, with working capital of 248.52M providing operational flexibility.
| Cash & Cash Equivalents | 258.47M |
| Total Debt | 33.35M |
| Net Debt | -4.72M |
| Equity (Book Value) | 199.98M |
| Book Value Per Share | 3.19 |
| Working Capital | 248.52M |
Cash Flow
enGene Holdings Inc. produced -110.00M in operating cash flow over the past twelve months. After subtracting -1.39M in capital expenditures, free cash flow totaled -111.39M - equivalent to -1.78 per share.
| Operating Cash Flow | -110.00M |
| Capital Expenditures | -1.39M |
| Free Cash Flow | -111.39M |
| FCF Per Share | -1.78 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -31.39 |
| FCF Yield | -23.83 |
Scores
enGene Holdings Inc. posts an Altman Z-Score of 2.80, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.80 |